METTL3 and cancer: In addition, TP53 mutation leads to increased expression of SUMO family members, suggesting that SUMO family members may be downstream targets regulated by TP53, and the overexpression of SUMO family genes may increase the expression levels of M6A methylation regulators with cancer-promoting effects.